Newsroom

WESTMONT, Ill.--(BUSINESS WIRE)--Gamma Technologies (GT), a global leader in multi-physics systems simulation software is proud to announce the launch of a new direct entity in Japan, Gamma Technologies G.K., a major step forward in strengthening our commitment to supporting innovation and transformation for our customers in the region. Complementing this strategic move, GT is also extending its long-standing strategic partnership with our exclusive distributor in Japan, IDAJ Co., Ltd., a premi...

BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop, Inc. announced today that it arranged a comprehensive financing package to facilitate the development of 22 Fulton Street, a premier, luxury multifamily project located within a Qualified Opportunity Zone in Newark, New Jersey. Walker & Dunlop Capital Markets Institutional Advisory, led by Aaron Appel, Keith Kurland, Jonathan Schwartz, Adam Schwartz, Jordan Casella, Michael Ianno, and Jackson Irwin, arranged the full financing package on...

NEW YORK & SINGAPORE--(BUSINESS WIRE)--Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, today announced the launch of Peregrine Cold Logistics (“Peregrine” or the “Platform”), a new cold chain logistics platform in Asia Pacific and the GCC, to meet the accelerating demand for temperature-controlled infrastructure across the region. Headquartered in Singapore, Peregrine will target cold chain opportunities across key markets including the ASEAN reg...

MALVERN, Pa.--(BUSINESS WIRE)--LifeScan (the “Company”), a world leader in blood glucose monitoring, today announced its successful emergence from its Chapter 11 financial restructuring process following approval of its Plan of Reorganization on October 27, 2025. Through this process, the Company eliminated more than 75% of its debt, providing the financial flexibility needed to continue its leadership in the glucose management industry. In connection with emergence, LifeScan is now owned by a...

DENVER--(BUSINESS WIRE)--Lumen Technologies, Inc. (“Lumen,” “us,” “we” or “our”) (NYSE: LUMN) today announced that its wholly-owned subsidiary, Level 3 Financing, Inc. (“Level 3 Financing”), has agreed to sell $1.25 billion aggregate principal amount of its 8.500% Senior Notes due 2036 (the “Notes”), which represents a $500 million increase from the previously announced size of the offering. The Notes were priced to investors at a price of 100.000% of their aggregate principal amount and will m...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), een mondiaal oncologisch bedrijf, herbevestigt zijn positie als leider in innovaties voor chronische lymfatische leukemie (CLL) door de breedte, kwaliteit en het momentum van zijn hematologisch portfolio te demonstreren op de 67ste jaarlijkse vergadering en expositie van ASH in Orlando, Florida. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp...

TORONTO--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company“) (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, announced today the filing of a preliminary prospectus supplement (the “Supplement”) to its short form base shelf prospectus dated October 31, 2025 (the “Base Prospectus”), in connection with a proposed public offering of 15 million of Almonty’s common shares (“Common Shares”) in the United States (the “Offering”...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), azienda farmaceutica oncologica globale, riafferma la sua posizione come leader innovativo nella leucemia linfatica cronica (LLC) mostrando la profondità, la qualità e lo slancio del suo portafoglio ematologico al 67o Meeting annuale ed Esposizione dell'American Society of Hematology (ASH) a Orlando, Florida. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione...

LOS ANGELES--(BUSINESS WIRE)--Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, presented scientific results on novel therapies, treatment strategies, and approaches to managing side effects and complications for blood cancer patients at the 2025 American Society of Hematology (ASH) conference in Orland...

SAN CARLOS, Californie--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq : ONC ; HKEX : 06160 ; SSE : 688235), une société mondiale d'oncologie, annonce aujourd'hui de nouvelles données sur le sonrotoclax, un inhibiteur de BCL2 expérimental de nouvelle génération, démontrant un bénéfice clinique significatif en monothérapie et en combinaison contre des tumeurs malignes à cellules B. Ces données ont été présentées lors de la 67e réunion annuelle de l'American Society of Hematology (ASH) à Orlando,...